Join CMS for the Innovation in Behavioral Health Model Overview Webinar

IBH Model Overview Webinar

Thursday, February 29
2 - 3:30pm ET

The Centers for Medicare & Medicaid Services (CMS) will host a webinar on Thursday, February 29, to provide an overview of the Innovation in Behavioral Health (IBH) Model.

During this webinar, the IBH Team will discuss the model’s goals, eligibility, participant types, care delivery framework, and payment structure. The team will also provide additional details on the application process, timeline, and resources.

The IBH Model’s goal is to improve the quality of care and health outcomes for people with moderate to severe behavioral health conditions, including mental health conditions and/or substance use disorders. The model will test a value-based payment approach that enables community-based behavioral health practices to integrate behavioral health care with physical health needs and health-related social needs.

Following the event, presentation materials will be available on the IBH Model webpage.

Please contact the IBH Help Desk at [email protected] with questions.


First Comprehensive Evidence-Based Guideline on Use of Fecal Microbiota-Based Therapies

Anne Peery, MD (image credit: UNC School of Medicine)

For use in patients with recurrent CDI at high risk of recurrence

The American Gastroenterological Association (AGA) has released the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, recommending fecal microbiota transplant (FMT) in most cases of recurrent Clostridioides difficile infection (CDI).

Specifically, the guideline recommends the use of FMT-based therapy in patients with recurrent CDI at high risk of recurrence following standard-of-care antibiotics and in hospitalized patients with severe CDI after standard-of-care antibiotics if there is no improvement. Of note, the AGA does not recommend FMT therapies for inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS).

“Using fecal microbiota transplant, we take stool from a healthy donor and transfer it to the colon of the person with recurrent C. diff, restoring balance to their gut microbiome,” Anne Peery, MD, associate professor of medicine and director of the adult inpatient nutrition support team at the University of North Carolina School of Medicine, said in a press release. “FMT is a safe and effective treatment with enough scientific evidence to be offered to most patients with two or more C. diff recurrences.”

Continue to full article here.


Reminder: Missed Opportunities for Preventing Congenital Syphilis Webinar is Wednesday

 

Missed Opportunities for Preventing Congenital Syphilis

Wednesday, February 28
Noon-1:00 p.m. ET

 

Join the Bureau of Primary Health Care (BPHC) in collaboration with Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention for a on Congenital syphilis webinar developed for clinicians and other health care providers.

This webinar will provide an overview of congenital syphilis and explore missed opportunities for preventing congenital syphilis as well as interventions for prevention.

Objectives of this presentation:

1) Understand the epidemiology of syphilis and congenital syphilis in the United States.
2) Diagnosis and counsel about syphilis and congenital syphilis.
3) Practical implementation of syphilis screening and treatment in the clinical setting.
4) Discuss missed opportunities to prevent congenital syphilis in the US and possible interventions.

For more information, contact: Chepkorir Maritim, Nurse Consultant, [email protected]


New CMS Vaccine Coverage and Payment Toolkit Offers Helpful Guidance

Understand federally funded Vaccines for Children program

This new CMS toolkit, Coverage and Payment of Vaccines and Vaccine Administration under Medicaid, the Children’s Health Insurance Program, and Basic Health Program (PDF), can help to understand coverage, cost-sharing, and payment for vaccines and vaccine administration.

The toolkit addresses the federally funded Vaccines for Children program and assists in navigating vaccination coverage requirements. This includes providing guidance regarding the commercialization of COVID-19 vaccines and the end of the American Rescue Plan Act COVID-19 vaccination coverage period (September 2024).


NC Medicaid: Reimbursement Changes to Popular Syphilis Treatment

 

As part of a larger effort to address rising rates of syphilis, including congenital syphilis, rates for Bicillin® L-A, Healthcare Common Procedure Coding System (HCPCS) Code J0561, increased as part of the recent changes NC Medicaid made to the Physician Administered Drug Program (PADP) fee schedule. This applies to NC Medicaid Managed Care and NC Medicaid Direct.

The rate for Bicillin® L-A increased effective February 1, 2024, for drugs administered in the physician’s office (as part of the PADP program). The rate increase reflects updated costs of the medication. Bicillin® L-A is a drug which can be used to treat syphilis and the only known effective treatment for preventing congenital syphilis. For more information on the PADP fee schedule change, please see the NC Medicaid to Revise the PADP Fee Schedule bulletin.

For more information on the PADP, please see the NC Medicaid Physician Administered Drug Program webpage. For the PADP fee schedule, please see Fee Schedules and select “Physician Administered Drug Program” from the Program or Fee Schedule drop down boxes and click “Apply Filters”.

This change to the reimbursement for Bicillin® L-A follows other actions by the NC Department of Health and Human Services (NCDHHS), including joining other southeastern states in partnership to combat the surge in congenital syphilis infections, establishing a provider resource webpage and a public education campaign.


NC University Launches New Eye and Vision Research Center

 

Wake Forest University School of Medicine has launched a new Translational Eye and Vision Research Center. Leaders envision the center serving as a visionary hub that will redefine the landscape of eye and vision research.

"The launch of the Translational Eye and Vision Research Center represents a profound commitment to advancing our understanding of vision and eye diseases,” said Ebony Boulware, M.D., dean of Wake Forest University School of Medicine. “We believe that this center will not only impact the lives of countless individuals but also foster collaboration and innovation in the broader scientific community. This center will serve as a cornerstone in our mission to establish Wake Forest University School of Medicine as a leader in vision excellence."

At its core, the center is dedicated to promoting translational and team-based research in vision and eye disease.

Central to the center's initiatives are pilot and travel award programs designed to expedite discovery and innovation. These programs will empower vision scientists and clinician-scientists to pursue groundbreaking research, driving remarkable progress in the field.

Read the full article here.


Nominations Open for NCMS Foundation Board of Trustees

The NCMS Foundation Board Development Committee Submits:

 

Call for Nominations: NCMS Foundation Board of Trustees Overview

Overview

The call for nominations for individuals to serve on the NCMS Foundation Board of Trustees is now open. Nominations are due by May 31, 2024 (view NCMS Foundation Candidate Application Form here).

The North Carolina Medical Society Foundation (NCMSF) is the philanthropic arm of the North Carolina Medical Society. The mission of the NCMSF is to improve access to quality health care for all North Carolinians. Our portfolio of programs demonstrates our commitment to this vision. Learn more about each of these programs here.

Those who serve on the NCMS Foundation’s Board of Trustees have general experience with and understanding of a philanthropic, 501c3 organization. Trustees are willing and able to articulate the purpose of each of the Foundation’s initiatives, and, ideally, will be able to offer details about their firsthand experience with a particular NCMS Foundation program and the value it brings to the profession and to North Carolina. Knowledge about the challenges health care professionals and their patients face and a desire to be innovative and collaborative in finding solutions is essential to this role. Fundraising ability also is crucial to fulfilling the Foundation’s mission of improving access to quality health care for everyone in the state.

In 2024, the NCMS Foundation will be filling the following leadership positions:

Board of Trustee: Up to two (2) Trustees to serve a three-year term.

Process

Step 1: Candidates are nominated or may nominate themselves for a position on the NCMS Foundation Board of Trustees (view NCMS Foundation Candidate Application Form here).

Step 2: Once a candidate submits their application form, they will receive a confirmation email and made aware of any follow-up if needed.

Step 3: Upon careful review of submitted materials, the NCMS Foundation Board Development Committee will select candidates to be interviewed. Candidates will be notified via email by June 7, 2024 if they are selected for an interview. Interviews will take place via videoconference on Wednesday, June 26, 2024.

Step 4: Following candidate interviews, the NCMS Foundation Board Development Committee will vote to select candidate(s) to fill open leadership positions. The NCMS Foundation Board of Trustees will approve the slate of candidates at the August 21, 2024 board meeting.

Step 5: The Board of Trustees slate of candidates will be submitted to the NCMS Board of Directors for approval and appointment at the November 2, 2024 board meeting.

*All nominations and any information collected as part of the nominating process is strictly confidential.


‘Beyond the Pink Runway’ Fundraiser Coming to Charlotte

Sandra Levine Theatre, Sarah Belk Gambrell Center

319 Wellesley Ave
Charlotte, NC 28207
March 2, 2024
6:30 p.m.

 

Atrium Health Levine Center cordially invites you to an event benefiting research, education, and support programs for the Sandra Levine Young Women's Breast Cancer Program.

The “Beyond the Pink Runway” event will be held Saturday, March 2 at the Sandra Levine Theater at Queens University. It will begin at 6:30 p.m. and will feature a cocktail party, fashion show, and silent auction.

Tickets and information on sponsorship opportunities can be found here.


NCDHHS Launches New Statewide Peer Support Line

 

Help with support and resources for those in crisis

 

On February 20, The North Carolina Department of Health and Human Services launched a new Statewide Peer Warmline.

The Peer Warmline is a phone line staffed by Peer Support Specialists who offer non-clinical support and resources to those in crisis. Specialists are available 24 hours a day, 7 days a week.

The new Peer Warmline will work in tandem with the North Carolina 988 Suicide and Crisis Lifeline by giving callers the option to speak with a Peer Support Specialist. Peer Support Specialists (or “peers”) are people living in recovery with mental illness and/or substance use disorder who provide support to others who can benefit from their lived experience.

Individuals in need of assistance and wanting to speak with a peer can call the warmline at 1-855-PEERS NC (1-855-733-7762), and people who call 988 will have the option to connect with the Peer Warmline if they prefer to speak with a peer.

Read the full press release here.


NC Mobile Health Unit Providing Easier Access to Quality Healthcare

"We see everyone regardless of their ability to pay."

Mobile health clinics can be an essential resource to those without access to quality healthcare. One such clinic, the Cone Health Mobile Medicine Unit, provides basic acute and primary care services, including patient education, diagnosis and treatment of acute and chronic illnesses.

In a recent interview, Dr. Olu Jegede, vice president of Clinical Care - Healthy Equity for Cone Health, answers questions about mobile medicine services:

Learn more about Cone Health's Mobile Health Program here.